# Director, Global Decision Sciences & Insights – Liver & Inflam Pipeline

Hiring organization: [Gilead Sciences](https://career.thegoodapps.co/organizations/gilead-sciences)

Canonical page: https://career.thegoodapps.co/jobs/9c7e48ef-6250-4672-bb6f-e3336f908820

Listed on Gilead Sciences's own careers site. Applications go to them directly.

- Employment type: full time
- Seniority: Director
- Salary: 226185 – 292710 USD per year

## Summary

This director role leads commercial forecasting, market research, and analytics for Gilead's liver and inflammation drug pipeline, translating clinical and market data into strategic business decisions. The position suits experienced commercial strategists in pharma who can manage complex quantitative models, conduct primary market research, and communicate insights to senior leadership across clinical and marketing teams.

_Our summary, not Gilead Sciences's wording._

## Skills named

Market Research, MicroStrategy, Tableau

## Required

- Bachelor's degree with 8+ years of experience, or Master's degree with 6+ years, or PhD with 4+ years
- Experience conducting and analyzing qualitative and quantitative global market research
- Knowledge of MS Excel and business intelligence tools (Microstrategy, Tableau)
- Strong business acumen and strategic thinking for pipeline decisions
- Ability to lead cross-functional teams and communicate technical insights to senior management
- Experience with forecasting and revenue modeling

## Nice to have

- Experience in liver diseases, inflammation, oncology, or HIV
- Experience supporting brand growth strategy at local and global levels
- Specialty market and pharmaceutical data source expertise (e.g., IQVIA)
- Patient-based market and revenue modeling experience
- Prior forecasting experience with similar products or therapeutic areas
- Openness to adopting AI to improve insights work

Apply on Gilead Sciences's site: https://gilead.wd1.myworkdayjobs.com/en-US/gileadcareers/job/United-States---California---Foster-City/Director--Global-Decision-Sciences---Insights---Liver---Inflam-Pipeline_R0053369-1